Laboratory of Genome Technology

Our laboratory is involved in the management of Biobank Japan (BBJ), one of the largest disease biobank in the world, that has approximately 270,000 samples. By using BBJ samples, we conducted comprehensive genomic analysis to identify genetic factors associated with disease risk and various phenotypes for the implementation of personalized medicine. In addition, we are also working on the project for the identification of downstream targets of p53 and genomic analysis of bone and soft tissues tumors to elucidate the molecular mechanism of human carcinogenesis.